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Wavelength-dependent optoacoustic imaging
probes for NMDA receptor visualisation†
Neil Sim,a Sven Gottschalk,b Robert Pal,a Martina Delbianco,a Oleksiy Degtyaruk,b
Daniel Razansky,bc Gil G. Westmeyer,bde Vasilis Ntziachristos,bf David Parker*a and
Anurag Mishra*b
The cellular localisation and binding specificity of two NMDAR-
targeted near-IR imaging probes has been examined by micro-
scopy, followed by exemplification of MSOT to monitor simulated
glutamate bursts in cellulo and a preliminary study inmice observing
the signal in the brain.
Glutamate (Glu) is an important excitatory chemical messenger
in the central nervous system (CNS), involved in many signalling
functions between neurons. Its release from synaptic vesicles to the
synaptic cleft is stimulated by electrically induced calcium influx
into the presynaptic terminal and its eﬀects are induced following
binding to postsynaptic receptors.1,2 Ionotropic N-methyl-D-
aspartate receptors (NMDARs) are widely localised on the post-
synaptic cell membrane and play a crucial role in impaired
neural circuit operations that incitemany devastating phenomena of
the brain.1,2 Slight disturbances in the NMDAR signalling pathway
may lead to neuropsychiatric pathologies such as schizophrenia,
Alzheimer’s disease, and certain mood disorders.3,4
Multi-spectral optoacoustic tomography (MSOT) is a non-
invasive method that applies multi-wavelength illumination to
identify the spectral signatures of any absorbers of interest.5,6
MSOT has a penetration of several cm into living tissue,5 high
spatial resolution (100 mm independent of photon scattering),
ultrasensitive detection of intrinsic tissue chromophores and
probes (nM), as well as real-time imaging capability.6 However,
MSOT will only develop beyond addressing haemodynamic
changes,7 if tailored optoacoustic (OA) imaging probes can be
devised. Here, we introduce OA imaging probes that bind
selectively to NMDARs and non-invasively can track concentration
changes of Glu in tissue with good sensitivity and spatio-temporal
resolution.
This approach may not only be used to image receptor
density but also may allow sensing of Glu concentration
changes via MSOT. We have developed two NMDAR-targeted
imaging probes, L1 and L2 (Scheme 1) for MSOT. These probes
are based on a heptamethine cyanine dye, conjugated to both
competitive and non-competitive antagonists for selective
NMDAR-tagging. Receptor targeting via an antagonist-based
approach is promising, as the receptors do not normally get
internalised into cells via receptor mediated endocytosis.8
Recently, the non-competitive antagonist, Ifenprodil,9 has been
conjugated to a red-fluorescent pentamethine cyanine dye10
and an NMDAR antagonist has been linked to a Gd complex to
create an MRI probe11 for selective NMDAR imaging.
The core heptamethine cyanine dye precursor 5 (Scheme 1)
is well suited as a strongly absorbing chromophore for use in
MSOT. The synthesis began with construction of the hetero-
cyclic indole ring, via quaternary ammonium salt formation
and condensation (Scheme S1, ESI†). The amine precursors 10/12
were made using standard methodology, via alkylation, mesylation–
amination, coupling, amide formation, and protection steps
(Schemes S2 and S3, ESI†). L1 and L2 were obtained by coupling
the amine 10/12 and the mono-acid, 5, [HATU/DIPEA] in anhydrous
DMF (Scheme S4, ESI†).
The presence of the negatively charged sulfonate groups
reduces non-specific binding to endogenous proteins.12 The
Scheme 1 OA imaging probes for NMDAR-tagging.
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absorption spectra of each probe showed broad absorption
bands centred at 776 nm, with a secondary band at 712 nm
(Scheme S4, ESI†). The optoacoustic signal of L1 and L2 replicate
the absorption spectra in aqueous solution (Scheme S4, ESI†).
The extinction coeﬃcient of each dye at 776 nm was
240 000 M1 cm1, consistent with an intense p - p* (0 - 0
vibronic) transition. The shoulder at 712 nm is also p - p*
mode, relating to the 0 - 1 or 0 - 2 vibronic transitions.13
These absorption properties makes them excellent candidates
as NMDAR-targeted probes for MSOT, with the maximum
wavelength of absorption falling in the near-infrared (NIR)
window where the majority of endogenous chromophores do
not strongly absorb. In this region, light scattering is relatively
low resulting in greater light penetration, allowing images to be
obtained from deeper within the body. The emission spectra of
L1 and L2 were measured (lexc 776 nm) and were structurally the
same, with one main emission band at 801 nm, giving a Stokes’
shift of 25 nm (Scheme 1). The quantum yields (5–10%) fell in
the range of similar dye structures.14
The in cellulo studies were performed on diﬀerentiated NSC-34
cells expressing receptor subunits NMDAR-2B and NMDAR-1 at
high densities, as shown earlier.11,15 None of these probes exhibited
significant cytotoxicity after 24 h (MTT), at concentrations of up to
100 mM. To determine the live cell-surface co-localisation profile
of L1 and L2, two optical microscopic techniques were explored
to visualise NMDARs on live neuronal cells (NSC-34). The probes
were first visualised upon cell surface NMDARs-tagging using
epifluorescence microscopy following direct excitation (lexc 4
750 nm). Diﬀerentiated NSC-34 cells expressing NMDARs were
incubated with the probes [5 (as a control), L1 or L2 (10 mM,
30 min)] and then washed with Hank’s balanced salt solution
(HBSS) to remove unbound probe. L1 and L2 showed complete
NMDAR-probe visualisation in fluorescence mode (Fig. S3,
ESI†). Larger signal intensity was detected from cells treated
with L1, suggesting a higher receptor aﬃnity. No signal was
obtained from cells upon incubation with the control dye 5,
consistent with specific binding of L1 and L2 on the NMDARs
(Fig. S3, ESI†).
A second microscopic technique was used to confirm that
the probes were at the cell surface. Using a FRET-based assay,
L1 and L2 were acceptors, excited by a non-internalised Eu(III)
complex16 [EuL]3 (Fig. 1), as the donor. Excitation of [EuL]3 at
365 nm led to population of the dye excited state. Spectral overlap
of the DJ = 4 emission band of the donor with the absorption
spectrum of the acceptor led to excitation of L1 and L2, indicating
donor and acceptor in close proximity (Fig. 1). Emission from the
acceptor was also observed above 780 nm.
A study of the energy transfer process was first performed
in vitro to confirm this possibility. As a reference NIR dye, the
commercially available Dy-647-NH2 was chosen as the acceptor.
Changes in the [EuL]3 emission lifetime were monitored as a
function of the concentration of NIR dyes [L1 and Dy-647-NH2].
Stern–Volmer analysis showed 65% energy transfer efficiency
between [EuL]3 and L1, less than that calculated for Dy-647-NH2
(93%), due to reduced spectral overlap (Fig. 1). The differentiated
NSC-34 cells were incubated with a 10 mM solution of either L1 or
L2 for 30 minutes and washed to remove unbound probe. The cells
were treated with fresh buffer containing 20 mM of [EuL]3, and
imaged using a modified Zeiss Axiovert 200M inverted micro-
scope.17 Excitation at 365 nm and observation of the time-gated
emission (6 ms delay) above 780 nm demonstrated that both L1
and L2 gave rise to a localisation profile at the cell surface
(Fig. 2B and D), with L1 appearing to label the cells more readily
than L2. Using the same cell preparation, live cell imaging
studies were also performed consistent with the hypothesis of
selective probe-receptor tagging at the cell surface (Fig. 2D).
Confirmation of cell-surface localisation was achieved by repeat-
ing the loading experiment with a co-incubation of the commer-
cially available, plasma membrane stain, CellMask Orange (5 mg
mL1 for 5 min) (Fig. 2A and C).
The cellular NMDAR-probe binding specificity was further
proven by studies on NMDAR-negative cells (NIH 3T3 mouse
skin fibroblast cells). These cells were incubated with a solution
of either L1 or L2 (10 mM 30 min.), washed to remove unbound
probe and treated with [EuL]3 (20 mM). No localisation profile
was observed, strengthening the case for receptor-mediated
localisation of L1 and L2 with diﬀerentiated NSC-34 cells.
One further characteristic for these probes is the ability to
bind reversibly at the NMDAR, with an aﬃnity competitive with
endogenous Glu. Since L1 was visualised on the cell surface
receptors, the binding of this probe after a simulated ‘Glu burst’
was assessed. The diﬀerentiated NSC-34 cells were consecutively
incubated with L1 (10 mM, 30 min, 3 HBSS wash), Cell Mask
Orange (5 mg mL1, 5 min, 2HBSS wash) and then treated with
fresh buﬀer containing 20 mM of [EuL]3. The cells were imaged
and the average intensity was recorded in triplicate. These cells
were washed with a Glu-rich (2, 1 mM)medium and then treated
with buﬀer containing 20 mM of [EuL]3. This sequence resulted in
a ten-fold drop in fluorescence intensity (Fig. 2F and G),
compared to the original cell staining experiment (Fig. 2B),
whilst the non-specific membrane dye maintained the same
intensity (Fig. 2E).
To demonstrate the suitability of the probes for OA detection, the
probes were assessed by MSOT after interaction with cell surface
NMDARs on diﬀerentiated NSC-34 cells. These experiments were
Fig. 1 L1 dye absorption (green) and [EuL]3 emission (red) spectra, (H2O,
pH 7.2, 295 K). Table: quenching studies for [EuL]3with L1 orDy-647-NH2 as
acceptor. (data (5%), 295 K, 50mMHEPES, 50mMNaCl, pH 7.4; lex 332 nm).
Weak Eu transitions at 750 and 800 nm (DJ = 5 and DJ = 6 manifolds) are
not shown.
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conducted using a small animal MSOT scanner. In brief, about 106
diﬀerentiated NSC-34 cells were treated with 20 mMof either 5, L1 or
L2 for 30 minutes, washed thoroughly to remove any unbound
probe and were then re-suspended in a 1 :1 mixture of fresh buﬀer
and a 3% agar solution. The agar solution generated a scattering
pattern mimicking tissue scattering. Images were obtained by
scanning wavelengths between 700–900 nm in 5 nm steps, with
20 averages each (Fig. 3 and Fig. S4, ESI†).
L1 clearly labels NSC-34 cells, generating a strong optoacoustic
signal (Fig. 3C).18 As a control, untreated cells (Fig. 3A) and cells
treated with the non-targeted heptamethine cyanine dye, 5
(Fig. 3B) did not show any OA signal, suggesting that the
receptor-binding moiety of L1 binds to the cell surface NMDARs
and is responsible for the observed OA signal. However, cell
labelling with L2 (20 mM, 30 min) gave rise to only a faint OA
signal (Fig. 3D) replicating results obtained from fluorescence
microscopy when comparing the labelling eﬃciencies of L1 vs.
L2. Fig. 3 (right panel) shows the wavelength dependence of the
optoacoustic signals of cells treated with L1/L2. The cell bound OA
spectrum of L1 was significantly diﬀerent from the OA spectrum of
supernatant L1 (Fig. 3.1). An enhanced intensity around 700 nm
and a decreased intensity around 780 nm suggests that bound and
unbound probe can be distinguished and will potentially be
observable in an in vivo model, in the presence of endogenous
photo-absorbers. This switchable intensity was confirmed upon
treating cells with L1, washed twice with HBSS and recording the
normalised absorption spectrum (Fig. S5, ESI†). The absorption
maximum for cell-bound L1 clearly undergoes a hypsochromic
shift to around 694 nm, compared to the absorbance maxima at
774 nm for L1 alone. The cell bound OA spectrum of L2 was the
same as the OA spectrum of supernatant L2 (Fig. 3.2).
The absorption spectra involve p - p* transitions that are
aﬀected by the local solvent polarity. A hypsochromic shift in
the cell-bound-L1 absorption maxima suggests that the probe is
in a less polar environment, as compared to the probe alone.
The similar behaviour of Indocyanine Green (ICG) has been
explained by Landsman; ICG shows a hypsochromic shift when
the plasma concentration increased.19 It is also known that the
ifenprodil-binding site is buried deep within the interface
between the GluN1 and GluN2B subunit ATD dimers, suggesting
an induced-fit mechanism of binding, with dissociation likely to
involve opening of the GluN2B ATD bi-lobed structure.20 As the
binding site is deep within the NMDAR cleft, the cavity is more
hydrophobic than in normal solution, leading to the shift in
absorption wavelength. Furthermore, a competition experiment
was performed to assess the cellular labelling of L1 in the presence
of the antagonist Ifenprodil. Diﬀerentiated NSC-34 cells were
treated with a 40 mM solution of Ifenprodil for 10 minutes
(2 HBSS wash), then incubated with a 20 mM solution of L1 for
30 minutes (2 HBSS wash) and imaged using MSOT. Pre-treating
cells with the NMDAR-bindingmoiety of L1 before loading the cells
with L1 gave a diminished OA signal (Fig. 3E). Such behaviour
suggests that the NMDAR binding eﬃciency of L1 is slightly less
Fig. 2 Live cell fluorescence microscopy images of diﬀerentiated NSC-34
cells following treatment with L1 and L2 (10 mM, 30 min, 37 1C and 5% CO2)
followed by Cell Mask Orange (CMO) (5 mg mL–5 min) showing cell
surface localisation. (A–D) (A) visualisation of plasma membrane by CMO
(lex/lem = 525/590 nm); (B) L
1 visualisation by FRET using [EuL]3
(lex/lem = 365/780 nm). (C and D) Analogous to images (A and B) but
incubation with L2. (E and F): incubation with L1, followed by CMO,
followed by glutamate wash (2, 1 mM); (E) plasma membrane visualisation
by CMO; (F) no detectable signal of L1 (lex/lem = 365/780 nm), showing the
reversibility of binding in the presence of Glu. (G) Gaussian distribution plot
of recorded intensity count of a unified stained cell standardising the
average contrast transfer function (CTF) intensities to themaximum brightness
of the original loading experiment. Original simultaneous loading experiment
of L1 (10 mM), (green 13600 counts) compared to the post-glutamate wash
(purple 160 counts, 1.2%). [Bars = 20 mm,63/1.40 NA oil, 1300 1030 pixels/
frame, dx,y = 138 nm], [bars = 20 mm].
Fig. 3 Live cell OA signal of diﬀerentiated NSC-34 cells following treatment
with 5, L1 or L2 (each 20 mM, 30 min, 37 1C and 5% CO2). (Left) (A) Untreated
cells; (B) cells treated with control dye, 5, no OA signal; (C) cells treated with L1
(D) cells treated with L2 (E) cells treated with the corresponding antagonist,
Ifenprodil (40 mM, 10min), followed by treatment with L1 (C and F) cells treated
with L1 and washed with Glu (2, 1 mM), strong reduction in OA signal. (Right)
Absorbance spectrum of 5, L1 and L2 that are fed into the unmixing algorithm.
Wavelength-dependent analysis of NSC-34 labelled with 5, L1 or L2. (1–2).
Compared optoacoustic signal of L1/L2 (supernatant) vs. cell bound-L1/L2.
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than with Ifendopril. Similar behaviour was reported for a cyanine
dye conjugate.10 The ability of L1 to be displaced from the NMDAR
by the natural ligand L-Glu was demonstrated using MSOT.
Diﬀerentiated NSC-34 cells were treated with 20 mM solution of
L1 for 30 minutes and washed with L-Glu-rich (1 mM, 2 wash)
HBSS before being imaged. A greatly diminished OA signal was
observed (Fig. 3F), showing that L1 is displaced by a simulated L-Glu
burst, in accord with the fluorescence microscopy experiments.
To visualise the imaging probes under the skull via MSOT,
preliminary in vivo studies were undertaken. The motor cortex
of the mouse has a high expression of NMDARs.1,20 Therefore,
L1 and 5 were injected intracranially into the motor cortex.
MSOT successfully visualised L1 deep inside the brain tissue,
while 5 was not visualised, presumably being flushed away by
the blood flow. An ex vivo cryoslicer-imaging study (30 min
post-injection) showed that fluorescent probe L1 was inside the
brain (Fig. S6A and B, ESI†).
In summary, the results obtained concerning the localisa-
tion, cellular specificity and reversibility of binding suggest that
L1 and L2 are binding to the cell surface via their NMDAR-
binding moieties. The reversibility of L1 binding to the NMDAR
was shown via MSOT studies, showing that Glu addition leads
to probe release from the receptor site. The work paves the way
for development of probes capable of visualising NMDAR den-
sities in models of neuropsychiatric disease, suggesting that
dynamic changes in Glu concentration in vivomay bemeasured via
non-invasive MSOT imaging, serving as an alternative to lower
resolution PET imaging.
We thank the European Research Council [ERC-ADvG:
266804 (NS, RP, DP) and 233161 (VN), ERC-StG: 260991 (SG,
DR) and 311552 (GGW)], the Helmholtz Alliance ICEMED
(AM, GGW).
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